BACKGROUND: Incretin-based therapies such as glucagon-like peptide-1 receptor agonists (GLP-1Ras), dual GLP-1/GIP agonists and amylin analogues have demonstrated significant weight loss benefits
Gyms, wearables, activewear, and healthtech are all benefiting as GLP-1s serve as an entry point for a new wave of wellness consumers
This GHR upregulation sensitises local cells to circulating GH, potentiating GH-induced JAK2/STAT signalling and stimulating collagen matrix synthesis, IGF-1 production, and fibroblast proliferation providing a mechanism through which BPC-157 engages the GH/IGF-1 axis at the tissue level without altering systemic GH secretion
Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality
-MSH Analog Cyclic Heptapeptide University of Arizona Originator Literature Reported Mechanism (Literature) Non-Selective Melanocortin Receptor Agonist Pan-MCR activation (MC1R, MC3R, MC4R, MC5R) Al-Obeidi and colleagues (1989, PMID 2555512) designed Melanotan II as a non-selective melanocortin receptor agonist with 100-fold enhanced melanotropic potency versus -MSH in the lizard skin bioassay
Rybelsus 3 mg Tablet Summary of Product Characteristics